FDA Warns of ‘Serious’ Respiratory Problems With Gabapentin
The FDA is warning of serious, life-threatening respiratory problems associated with gabapentin.
Related Articles
First Patient-Derived Stem Cell Transplant a Success in T1D
At 1 year, islets chemically reprogrammed from the patient’s own somatic cells allowed them to become insulin-independent with the use of immunosuppression.
Biosimilars in Rheumatology: Building Certainty and Reducing Reluctance
Do you know how to explain biosimilars to patients?
« Entendre de la bouche d’un professionnel de santé qu’on est aidant permet souvent de se sentir légitime, reconnu »
A l’occasion de la journée nationale consacrée aux aidants, ce 6 octobre, la Dre Hélène Rossinot, spécialiste en santé publique et experte sur la question…
How Can GPs Navigate the Complexities of Chronic Pain Management?
Dr Anish Kotecha revisits the NICE guideline on chronic pain, exploring the benefits and challenges of its implementation in everyday practice
Time-Restricted Eating Is Not a Metabolic Magic Bullet
This lifestyle change wasn’t effective in reversing a lifestyle disease.
Cannabis Use Rising in Diabetes: What Do Endos Need to Know?
With little in the way of evidence or professional guidance, endocrinologists have been left on their own when it comes to advising patients.
Inclusive HIV Prevention & Care: Are You Up to Date on Best Practices?
Learn where your clinic falls on the spectrum of inclusivity.
Hidradenitis Suppurativa Symptoms Eased by Semaglutide-Aided Weight Loss
Improvements in the Dermatology Life Quality Index score and hidradenitis suppurativa flares were seen in people who achieved semaglutide-induced weight loss.
« Entendre de la bouche d’un professionnel de santé qu’on est aidant permet souvent de se sentir légitime, reconnu »
A l’occasion de la journée nationale consacrée aux aidants, ce 6 octobre, la Dre Hélène Rossinot, spécialiste en santé publique et experte sur la question…
‘Cancer Doesn’t Wait’: How Prior Authorization Harms Care
“The people with the very worst prior authorization stories aren’t here anymore to tell you about them,” one expert said.